Delivery Order SPE2DB25D2207-SPE2DB25FQRUT
- Not listed
- The Defense Logistics Agency awarded a $9.73K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by October 3, 2025, and fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract. The order, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a direct procurement of this specialized pharmaceutical product to support federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This firm fixed-price delivery order, awarded on June 16, 2025, represents fulfillment under the company's larger pharmaceutical supply contract with DLA. The award was made through open competition with no set-aside designation, with ultimate completion scheduled for July 9, 2025. AmerisourceBergen will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed-price contract. The order is scheduled for completion by September 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract that reflects the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 for Venclexta 100 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) with a completion date of September 16, 2025. This competitive award, issued on August 25, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets in quantities of 120s. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units, with a ceiling value of $9,728.17 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply transaction supporting federal medical procurement needs. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 on June 16, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for 120 units of Venclexta 100 mg tablets, with a completion deadline of May 16, 2025. This non-set-aside, firm fixed price delivery order is being fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger federal contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's existing...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRUTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on September 18, 2025, with completion targeted for October 9, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken and is part of the company's broader federal medical supply portfolio serving Defense Health Agency and military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialty healthcare commodities to support military and federal healthcare programs worldwide. AmerisourceBergen's established track record of competitively awarded federal contracts and its designation as a pharmaceutical prime vendor demonstrate its capability to meet the Defense Logistics Agency's critical medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/18/25 |